AOD 9604 + NAD+ Combining AOD 9604 with NAD+ therapy at Perfect B in Doral targets two separate axes of metabolic function: NAD+ addresses cellular energy metabolism, mitochondrial efficiency, and metabolic resilience at the enzymatic level, while AOD 9604 drives fat mobilization from adipose tissue
Working concentrations vary widely across published protocols depending on whether the study is in-vitro, animal, or topical, so researchers should set concentration to their own study design
This article presents a study in which a prediction model for BE based on GERD, age, abdominal obesity and cigarette use with an AUC of 0.72 is developed in 822 male patients with colorectal cancer who are screened using upper endoscopy
Look for reduced inflammation within the first week, visible wound size reduction by week 2-3, and accelerated re-epithelialization compared to similar past wounds